ING Groep NV raised its stake in shares of Envision Healthcare Co. (NYSE:EVHC) by 73.4% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 10,442 shares of the company’s stock after purchasing an additional 4,420 shares during the period. ING Groep NV’s holdings in Envision Healthcare were worth $469,000 at the end of the most recent reporting period.

A number of other hedge funds also recently modified their holdings of the stock. Commonwealth Bank of Australia grew its stake in Envision Healthcare by 24.3% during the second quarter. Commonwealth Bank of Australia now owns 2,096 shares of the company’s stock worth $130,000 after buying an additional 410 shares during the period. LMR Partners LLP purchased a new stake in Envision Healthcare during the second quarter worth approximately $205,000. Palisade Capital Management LLC NJ purchased a new stake in Envision Healthcare during the third quarter worth approximately $229,000. Cutter & CO Brokerage Inc. grew its stake in Envision Healthcare by 11.1% during the second quarter. Cutter & CO Brokerage Inc. now owns 3,668 shares of the company’s stock worth $230,000 after buying an additional 367 shares during the period. Finally, Flinton Capital Management LLC grew its stake in Envision Healthcare by 18.7% during the second quarter. Flinton Capital Management LLC now owns 4,464 shares of the company’s stock worth $280,000 after buying an additional 704 shares during the period.

Several equities research analysts have issued reports on the stock. Mizuho decreased their price objective on shares of Envision Healthcare from $65.00 to $57.00 and set a “neutral” rating for the company in a research note on Wednesday, August 9th. Citigroup downgraded shares of Envision Healthcare from a “buy” rating to a “neutral” rating and set a $31.00 price objective for the company. in a research note on Thursday, November 2nd. BidaskClub downgraded shares of Envision Healthcare from a “sell” rating to a “strong sell” rating in a research note on Thursday, August 17th. Bank of America decreased their price objective on shares of Envision Healthcare from $72.00 to $60.00 and set a “buy” rating for the company in a research note on Monday, October 9th. Finally, Canaccord Genuity reiterated a “buy” rating and set a $32.00 price objective (down from $68.00) on shares of Envision Healthcare in a research note on Thursday, November 2nd. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating, ten have given a buy rating and one has given a strong buy rating to the stock. Envision Healthcare currently has an average rating of “Buy” and an average target price of $47.57.

Envision Healthcare Co. (NYSE EVHC) opened at $30.72 on Wednesday. The firm has a market cap of $3,614.59, a price-to-earnings ratio of 9.23, a PEG ratio of 0.78 and a beta of 0.69. The company has a quick ratio of 3.00, a current ratio of 3.01 and a debt-to-equity ratio of 0.89. Envision Healthcare Co. has a 52 week low of $23.77 and a 52 week high of $74.75.

Envision Healthcare (NYSE:EVHC) last announced its earnings results on Tuesday, October 31st. The company reported $0.73 earnings per share for the quarter, missing the consensus estimate of $0.81 by ($0.08). The firm had revenue of $1.99 billion during the quarter, compared to analysts’ expectations of $2.03 billion. Envision Healthcare had a negative net margin of 6.39% and a positive return on equity of 4.88%. Envision Healthcare’s revenue for the quarter was up 142.0% compared to the same quarter last year. During the same quarter last year, the company posted $1.13 earnings per share. analysts anticipate that Envision Healthcare Co. will post 2.57 EPS for the current fiscal year.

Envision Healthcare declared that its Board of Directors has authorized a stock repurchase plan on Monday, September 18th that permits the company to repurchase $250.00 million in shares. This repurchase authorization permits the company to repurchase up to 4.5% of its stock through open market purchases. Stock repurchase plans are typically a sign that the company’s management believes its shares are undervalued.

ILLEGAL ACTIVITY NOTICE: This story was originally posted by Watch List News and is owned by of Watch List News. If you are viewing this story on another domain, it was copied illegally and republished in violation of U.S. & international copyright & trademark legislation. The original version of this story can be viewed at https://www.watchlistnews.com/envision-healthcare-co-evhc-shares-bought-by-ing-groep-nv/1732803.html.

Envision Healthcare Company Profile

Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.

Want to see what other hedge funds are holding EVHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Envision Healthcare Co. (NYSE:EVHC).

Institutional Ownership by Quarter for Envision Healthcare (NYSE:EVHC)

Receive News & Ratings for Envision Healthcare Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare Co. and related companies with Analyst Ratings Network's FREE daily email newsletter.